SNF5/INI1 deficiency redefines chromatin remodeling complex composition during tumor development

Molecular Cancer Research

Volumn 12, Issue 11, 2014, Pages 1574-1585

  Wei, Darmood ^a   Goldfarb, Dennis ^b   Song, Shujie ^a,c   Cannon, Courtney ^a,d   Yan, Feng ^a   Sakellariou Thompson, Donastas ^a   Emanuele, Michael ^a,d   Major, Michael B ^a,d   Weissman, Bernard E ^a,d   Kuwahara, Yasumichi ^a,e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Brooks Computer Science Building   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEASOME INHIBITOR; PROTEIN; SHORT HAIRPIN RNA; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; DNA BINDING PROTEIN; LEUPEPTIN; MESSENGER RNA; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BRAIN; CANCER CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE; CHILDHOOD CANCER; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPLEX FORMATION; GENE; HUMAN; HUMAN CELL; INI1 GENE; KIDNEY; MASS SPECTROMETRY; NEOPLASM; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SUBUNIT; SNF5 GENE; STAINING; WESTERN BLOTTING; DEFICIENCY; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; RHABDOID TUMOR; TUMOR CELL LINE;

CARCINOGENESIS; CELL LINE, TUMOR; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUPEPTINS; PROTEASOME INHIBITORS; RHABDOID TUMOR; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84910662862     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-14-0005     Document Type: Article

References (48)

1. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 2004;4:133-42.
2. Biswas A, Goyal S, Puri T, Das P, Sarkar C, Julka PK, et al. Atypical teratoid rhabdoid tumor of the brain: case series and review of literature. Childs Nerv Syst 2009;25:1495-500.
3. McKenna ES, Sansam CG, Cho Y-J, Greulich H, Evans JA, Thom CS, et al. Loss of epigenetic tumor suppressor SNF5 leads to cancer without genomic instability. Mol Cell Biol 2008;28:6223-33.
4. Wei D, Weissman BE. Genetics and Genomics of Malignant Rhabdoid Tumours eLS 2014. Chichester: John Wiley & Sons Ltd; 2014.
5. Doan DN, Veal TM, Yan Z, Wang W, Jones SN, Imbalzano AN. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes. Oncogene 2004;23:3462-73.
6. Chen J, Archer TK. Regulating SWI/SNF subunit levels via proteinprotein interactions and proteasomal degradation: BAF155 and BAF170 limit expression of BAF57. Mol Cell Biol 2005;25:9016-27.
7. Curtis BJ, Zraly CB, Marenda DR, Dingwall AK. Histone lysine demethylases function as co-repressors of SWI/SNF remodeling activities during Drosophila wing development. Dev Biol 2011;350: 534-47.
8. Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 2001;186: 136-45.
9. DelBove J, Rosson G, Strobeck M, Chen J, Archer TK, Wang W, et al. Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene. Epigenetics 2011; 6:1444-53.
10. Jung I, Sohn DH, Choi J, Kim JM, Jeon S, Seol JH, et al. SRG3/mBAF155 stabilizes the SWI/SNF-like BAF complex by blocking CHFR mediated ubiquitination and degradation of its major components. Biochem Biophys Res Commun 2012;418:512-7.
11. Moshkin YM, Mohrmann L, van Ijcken WF, Verrijzer CP. Functional differentiation of SWI/SNF remodelers in transcription and cell cycle control. Mol Cell Biol 2007;27:651-61.
12. Zraly CB, Middleton FA, Dingwall AK. Hormone-response genes are direct in vivo regulatory targets of Brahma (SWI/SNF) complex function. J Biol Chem 2006;281:35305-15.
13. Ho L, Ronan JL, Wu J, Staahl BT, Chen L, Kuo A, et al. An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci 2009;106:5181-6.
14. Kadoch C, Crabtree GR. Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma. Cell 2013;153:71-85.
15. Lessard J, Wu JI, Ranish JA, Wan M, Winslow MM, Staahl BT, et al. An essential switch in subunit composition of a chromatin remodeling complex during neural development. Neuron 2007;55:201-15.
16. Chai J, Charboneau AL, Betz BL, Weissman BE. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res 2005;65:10192-8.
17. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbridge EJ. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 1987;236:175-80.
18. Weissman BE, Stanbridge EJ. Characterization of ouabain-resistant, hypoxanthine guanine phosphoribosyl transferase-deficient human cells and their usefulness as a general method for the production of human cell hybrids. Cytogenet Cell Genet 1980;28: 227-39.
19. Reincke BS, Rosson GB, Oswald BW, Wright CF. INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells. J Cell Physiol 2003;194:303-13.
20. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-14.
21. Kaeser MD, Aslanian A, Dong MQ, Yates JR III, Emerson BM. BRD7, a novel PBAF-specific SWI/SNF subunit, is required for target gene activation and repression in embryonic stem cells. J Biol Chem 2008;283:32254-63.
22. Kuwahara Y, Charboneau A, Knudsen ES, Weissman BE. Reexpression of hSNF5 in malignant rhabdoid tumor cell lines causes cell cycle arrest through a p21(CIP1/WAF1)-dependent mechanism. Cancer Res 2010;70:1854-65.
23. DeCristofaro MF, Betz BL, Wang W, Weissman BE. Alteration of hSNF5/INI1/BAF47 detected in rhabdoid cell lines and primary rhabdomyosarcomas but not Wilms' tumors. Oncogene 1999;18: 7559-65.
24. Hast BE, Goldfarb D, Mulvaney KM, Hast MA, Siesser PF, Yan F, et al. Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. Cancer Res 2013;73: 2199-210.
25. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008;26:1367-72.
26. Xu K, Ma H, McCown TJ, Verma IM, Kafri T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Mol Ther 2001;3:97-104.
27. Jagani Z, Mora-Blanco EL, Sansam CG, McKenna ES, Wilson B, Chen D, et al. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nat Med 2010;16:1429-33.
28. Yamamichi N, Yamamichi-Nishina M, Mizutani T, Watanabe H, Minoguchi S, Kobayashi N, et al. The Brm gene suppressed at the posttranscriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential. Oncogene 2005;24:5471-81.
29. Wang J, Rao S, Chu J, Shen X, Levasseur DN, Theunissen TW, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature 2006;444:364-8.
30. Wang W, Cote J, Xue Y, Zhou S, Khavari PA, Biggar SR, et al. Purification and biochemical heterogeneity of the mammalian SWISNF complex. EMBO J 1996;15:5370-82.
31. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, et al. The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci U S A 2011;108:3665-70.
32. Asher G, Reuven N, Shaul Y. 20S proteasomes and protein degradation "by default". Bioessays 2006;28:844-9.
33. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol 1998;8:397-403.
34. Sohn DH, Lee KY, Lee C,OhJ, Chung H, Jeon SH, et al.SRG3 interacts directly with the major components of the SWI/SNF chromatin remodeling complex and protects them from proteasomal degradation. J Biol Chem 2007;282:10614-24.
35. Yan Z, Cui K, Murray DM, Ling C, Xue Y, Gerstein A, et al. PBAF chromatin-remodeling complex requires a novel specificity subunit, BAF200, to regulate expression of selective interferon-responsive genes. Genes Dev 2005;19:1662-7.
36. Cohen SM, Chastain PD II, Rosson GB, Groh BS, Weissman BE, Kaufman DG, et al. BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression. Nucleic Acids Res 2010;38:6906-19.
37. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M. Altered control of cellular proliferation in the absence of mammalian brahma (SNF2a). EMBO J 1998;17:6979-91.
38. Wang X, Sansam CG, Thom CS, Metzger D, Evans JA, Nguyen PT, et al. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. Cancer Research 2009;69: 8094-101.
39. Kuwahara Y, Wei D, Durand J, Weissman BE. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Mol Cancer Res 2013;11:251-60.
40. Brown SA, Imbalzano AN, Kingston RE. Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes Dev 1996;10:1479-90
41. Neely KE, Hassan AH, Wallberg AE, Steger DJ, Cairns BR, Wright AP, et al. Activation domain-mediated targeting of the SWI/SNF complex to promoters stimulates transcription from nucleosome arrays. Mol Cell 1999;4:649-55.
42. Zraly CB, Dingwall AK. The chromatin remodeling and mRNA splicing functions of the Brahma (SWI/SNF) complex are mediated by the SNR1/SNF5 regulatory subunit. Nucleic Acids Res 2012;40: 5975-87.
43. Bourgo RJ, Siddiqui H, Fox S, Solomon D, Sansam CG, Yaniv M, et al. SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity. Mol Biol Cell 2009; 20:3192-9.
44. Guidi CJ, Mudhasani R, Hoover K, Koff A, Leav I, Imbalzano AN, et al. Functional interaction of the retinoblastoma and ini1/snf5 tumor suppressors in cell growth and pituitary tumorigenesis. Cancer Res 2006;66:8076-82.
45. Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 2012;122:2983-8.
46. Betz BL, Strobeck MW, Reisman DN, Knudsen ES, Weissman BE. Reexpression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene 2002;21:5193-203.
47. Isakoff MS, Sansam CG, Tamayo P, Subramanian A, Evans JA, Fillmore CM, et al. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A 2005;102:17745-50.
48. Morozov A, Lee SJ, Zhang ZK, Cimica V, Zagzag D, Kalpana GV. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors. Clin Cancer Res 2007;13:4721-30.